NCT02701647

Brief Summary

The purpose of this study is to investigate whether the beneficial effect of treadmill training on people with Parkinson's disease can be enhanced by high- and low-frequency repetitive transcranial magnetic stimulation (rTMS).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 8, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
6 months until next milestone

Results Posted

Study results publicly available

October 31, 2019

Completed
Last Updated

November 22, 2019

Status Verified

June 1, 2018

Enrollment Period

2.2 years

First QC Date

January 19, 2016

Results QC Date

February 21, 2019

Last Update Submit

November 20, 2019

Conditions

Keywords

Transcranial Magnetic Stimulationmetaplasticitygait training

Outcome Measures

Primary Outcomes (1)

  • Fastest Walking Speed

    Each participant is instructed to walk for 14 meters at their fastest walking speed for three trials. The time taken for the middle 10 meter was recorded. The average of three trials is used for analysis.

    Baseline, 1 day post-intervention, 1 month post-intervention, 3 month post-intervention

Secondary Outcomes (5)

  • Timed-Up-and-Go Test (iTUG)

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

  • the Motor Section of Movement Disorders Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS III)

    Baseline, I day post-intervention, 1 month post-intervention and 3 months post-intervention

  • Walking Distance in a 2 -Minute Walk Test

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

  • Mini Balance Evaluation Systems Test Scores

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

  • Dual-task Timed-Up-and-Go Test (DT-TUG)

    Baseline, 1 day post-intervention, 1 month post-intervention, 3 month-post intervention

Other Outcomes (3)

  • Cortical Silent Period

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

  • Gradient of the Recruitment Curve ( Also Known as Stimulus-response Curve)

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

  • Short-interval-intracortical Inhibition

    Baseline, 1 day post-intervention, 1 month post-intervention and 3 months post-intervention

Study Arms (3)

25Hz-TT

EXPERIMENTAL

Participants will receive 4s train of 25-Hz rTMS pulses with 50s inter-train interval, with an intensity of 80% resting motor threshold (RMT). Participant will receive a total of 600 rTMS pulses in 6 minutes for each hemisphere and a total of 1200 pulses followed by 30 minutes of treadmill training.

Device: Repetitive transcranial magnetic stimulation (rTMS)Other: Treadmill training

1Hz-TT

EXPERIMENTAL

Participants will receive a total of 600 1-Hz rTMS pulses in 10 minutes for each hemisphere and a total of 1200 pulses ,with an intensity of 80% RMT, followed by 30 minutes of treadmill training.

Device: Repetitive transcranial magnetic stimulation (rTMS)Other: Treadmill training

Sham-TT

SHAM COMPARATOR

Sham rTMS will be applied over the same site as for real rTMS, however, with the cable of the coil disconnected. Another figure-of-eight coil using the same stimulation parameters (intensity, time, and frequency) as per 25Hz-TT group will be placed posterior to the subject's neck with the handle pointing backward to produce the same clicking sound effect. Sham rTMS will be followed by 30 minutes of treadmill training.

Device: Repetitive transcranial magnetic stimulation (rTMS)Other: Treadmill training

Interventions

Repetitive TMS (rTMS) is a painless and non-invasive technique for activation of cerebral cortex based on the principle of electromagnetic induction of an electric field in the brain. rTMS will be delivered to the scalp over the leg area of the bilateral motor cortex by using a Magstim Rapid magnetic stimulator. (Magstim Company, Whitland, UK) and 90 mm double cone coil.

1Hz-TT25Hz-TTSham-TT

Participants will proceed to 30 minute of treadmill training after rTMS. A safety harness without body weight support will be provided. 80% of participant's over ground maximum walking speed will be halved and used for warm-up. After warming up, walking speed will be increased by 0.2 km/h every 5 minutes. Progression will be given if patients could tolerate the belt speed with appropriate step length and walk with good stability for 5 minutes. Participants will maintain the maximum speed achieved for the rest of the session or adjusted as needed. Positive verbal feedback will be given to encourage large strides and upright posture during training. The participants will be instructed to walk on treadmill without holding onto the handrails if possible. Participants will perform warm up and cool down exercise to minimize training related-injury.

1Hz-TT25Hz-TTSham-TT

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with idiopathic Parkinson's disease by a neurologist
  • had been stable on anti-Parkinsonian medication
  • able to walk independently for 30 meters

You may not qualify if:

  • severe co-morbidity that may interfere with their ability to participate including significant orthopaedic or rheumatological conditions or disorders of peripheral nervous systems that may interfere with mobility or balance performance
  • a diagnosis of neurological disease other than PD
  • a history of psychiatric disorders
  • the impossibility of inducing motor evoked potentials (MEPs)
  • a score of less than 24 on the Mini-Mental State Examination
  • contraindication to TMS including personal or family history of seizure disorder, metal in the head, implants of medical devices such as cardiac pacemakers or medical pumps, females subjects who are pregnant, a history of neurosurgery
  • subjects with irrepressible tremor and / or dyskinesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Sciences

Hong Kong, 852, Hong Kong

Location

Related Publications (1)

  • Yang YR, Tseng CY, Chiou SY, Liao KK, Cheng SJ, Lai KL, Wang RY. Combination of rTMS and treadmill training modulates corticomotor inhibition and improves walking in Parkinson disease: a randomized trial. Neurorehabil Neural Repair. 2013 Jan;27(1):79-86. doi: 10.1177/1545968312451915. Epub 2012 Jul 10.

    PMID: 22785003BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Results Point of Contact

Title
Chloe Chung
Organization
The Hong Kong Polytechnic University

Study Officials

  • Margaret Mak, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2016

First Posted

March 8, 2016

Study Start

October 1, 2016

Primary Completion

December 1, 2018

Study Completion

May 1, 2019

Last Updated

November 22, 2019

Results First Posted

October 31, 2019

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will share

Data will be shared with researcher who provide a methodologically sound proposal

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 3 months and ending 3 years following article publication
Access Criteria
request through email

Locations